Kamada Ltd.

Science Park, Kiryat Weizmann, 7 Sapir St.
74140 Nes Ẕiyyona
Israel

Contact

About Kamada

Kamada is a public biopharmaceutical company developing, producing and marketing a line of specialty life-saving biopharmaceuticals using its proprietary chromatographic purification technologies. Licensed and marketed worldwide, several of these specialty therapeutics are currently undergoing advanced clinical trials.

Product portfolio of Kamada

Product portfolio

Show all

News about Kamada

14-Oct-2008 | research and development

Kamada Reports Positive Phase II Data with Inhaled AAT in Cystic Fibrosis

The Results Demonstrate the Product Has an Excellent Safety Profile and Shows Promising Signs of Efficacy, as Indicated by a Reduction in Lung Inflammation

Read news

31-May-2007 | research and development

Kamada reports excellent intermediate results of phase I clinical trials of aerosolized AAT for the treatment of lung diseases

Kamada, a biopharmaceutical company which develops, manufactures and markets life-saving medicines, has successfully concluded the first of two stages of ...

Read news

Show more news about Kamada

Here you will find Kamada Ltd.

Last viewed contents

Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies - Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs)

Go to page

Get the life science industry in your inbox

Kamada Ltd.

About Kamada

Product portfolio of Kamada

Product portfolio

News about Kamada

Kamada Reports Positive Phase II Data with Inhaled AAT in Cystic Fibrosis

Kamada reports excellent intermediate results of phase I clinical trials of aerosolized AAT for the treatment of lung diseases

Here you will find Kamada Ltd.

Last viewed contents

Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies - Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs)

Kamada Ltd.